AstraZeneca PLC (AZN) stock analysis

In our weekly check, AstraZeneca PLC is graded A (A to F). Of 25 checks on debt, profit, cash flow and trend: 23 pass, warnings: 1, red flags: 1.

About AstraZeneca PLC

AstraZeneca PLC is a Healthcare company (Drug Manufacturers - General) based in the United Kingdom, listed on NASDAQ as AZN.

What our checks show for AZN

Red flags

Warning signs

Strengths

Next earnings report: 2027-02-09

Similar companies

NVS · AMGN · MRK · GILD · NVO · PFE

Questions

What grade does AstraZeneca PLC (AZN) have?

In our weekly check, AstraZeneca PLC is graded A (A to F). Of 25 checks on debt, profit, cash flow and trend: 23 pass, warnings: 1, red flags: 1. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of AZN stock?

This week's biggest flags for AstraZeneca PLC: Slow recovery after falls, Deep past fall. In total 2 of 25 checks show a warning or a red flag.

What does AstraZeneca PLC do?

AstraZeneca PLC is a Healthcare company (Drug Manufacturers - General) based in the United Kingdom, listed on NASDAQ as AZN.

When does AstraZeneca PLC report earnings next?

The next earnings report is expected on 2027-02-09. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis